|
« First |
Prev |
|
1 |
2 |
3 |
|
Next |
Last » |
ID
|
Chr
|
Gene ID
|
Name
|
NCBI ID
|
NCBI Protein ID
|
Variants
|
00000006 |
11 |
AIP |
aryl hydrocarbon receptor interacting protein |
NM_003977.2 |
NP_003968.2 |
182 |
00000007 |
2 |
ALK |
anaplastic lymphoma receptor tyrosine kinase |
NM_004304.4 |
NP_004295.2 |
527 |
00000003 |
5 |
APC |
adenomatous polyposis coli, transcript variant 1 |
NM_001127511.2 |
NP_001120983.2 |
593 |
00000004 |
5 |
APC |
adenomatous polyposis coli, transcript variant 2 |
NM_001127510.2 |
NP_001120982.1 |
593 |
00000005 |
5 |
APC |
adenomatous polyposis coli, transcript variant 3 |
NM_000038.5 |
NP_000029.2 |
594 |
00000002 |
11 |
ATM |
ataxia telangiectasia mutated |
NM_000051.3 |
NP_000042.3 |
798 |
00000008 |
3 |
BAP1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
NM_004656.3 |
NP_004647.1 |
245 |
00000009 |
2 |
BARD1 |
BRCA1 associated RING domain 1 |
NM_000465.2 |
NP_000456.2 |
22 |
00000010 |
15 |
BLM |
Bloom syndrome, RecQ helicase-like |
NM_000057.2 |
NP_000048.1 |
290 |
00000011 |
10 |
BMPR1A |
bone morphogenetic protein receptor, type IA |
NM_004329.2 |
NP_004320.2 |
143 |
00000012 |
17 |
BRCA1 |
breast cancer 1, early onset, transcript variant 1 |
NM_007294.3 |
NP_009225.1 |
1207 |
00000013 |
17 |
BRCA1 |
breast cancer 1, early onset, transcript variant 2 |
NM_007300.3 |
NP_009231.2 |
1206 |
00000014 |
17 |
BRCA1 |
breast cancer 1, early onset, transcript variant 3 |
NM_007297.3 |
NP_009228.2 |
1207 |
00000015 |
17 |
BRCA1 |
breast cancer 1, early onset, transcript variant 4 |
NM_007298.3 |
NP_009229.2 |
1203 |
00000016 |
17 |
BRCA1 |
breast cancer 1, early onset, transcript variant 5 |
NM_007299.3 |
NP_009230.2 |
1207 |
00000017 |
13 |
BRCA2 |
breast cancer 2, early onset |
NM_000059.3 |
NP_000050.2 |
1117 |
00000018 |
17 |
BRIP1 |
BRCA1 interacting protein C-terminal helicase 1 |
NM_032043.2 |
NP_114432.2 |
215 |
00000019 |
15 |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
NM_001211.5 |
NP_001202.4 |
215 |
00000021 |
1 |
CDC73 |
cell division cycle 73 |
NM_024529.4 |
NP_078805.3 |
80 |
00000022 |
16 |
CDH1 |
type 1, E-cadherin (epithelial) |
NM_004360.3 |
NP_004351.1 |
296 |
00000023 |
12 |
CDK4 |
cyclin-dependent kinase 4 |
NM_000075.3 |
NP_000066.1 |
56 |
00000024 |
11 |
CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2), transcript variant 1 |
NM_000076.2 |
NP_000067.1 |
51 |
00000025 |
11 |
CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2), transcript variant 2 |
NM_001122630.1 |
NP_001116102.1 |
51 |
00000026 |
11 |
CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2), transcript variant 3 |
NM_001122631.1 |
NP_001116103.1 |
51 |
00000027 |
9 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A, transcript variant 1 |
NM_000077.4 |
NP_000068.1 |
74 |
00000028 |
9 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A, transcript variant 5 |
NM_001195132.1 |
NP_001182061.1 |
74 |
00000029 |
9 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A, transcript variant 4 |
NM_058195.3 |
NP_478102.2 |
78 |
00000030 |
9 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A, transcript variant 3 |
NM_058197.4 |
NP_478104.2 |
74 |
00000031 |
19 |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
NM_004364.3 |
NP_004355.2 |
43 |
00000032 |
11 |
CEP57 |
centrosomal protein 57kDa, transcript variant 1 |
NM_014679.4 |
NP_055494.2 |
123 |
00000033 |
11 |
CEP57 |
centrosomal protein 57kDa, transcript variant 2 |
NM_001243776.1 |
NP_001230705.1 |
123 |
00000034 |
11 |
CEP57 |
centrosomal protein 57kDa, transcript variant 3 |
NM_001243777.1 |
NP_001230706.1 |
123 |
00000035 |
22 |
CHEK2 |
transcript variant 1 |
NM_007194.3 |
NP_009125.1 |
466 |
00000036 |
22 |
CHEK2 |
transcript variant 2 |
NM_145862.2 |
NP_665861.1 |
466 |
00000037 |
22 |
CHEK2 |
transcript variant 3 |
NM_001005735.1 |
NP_001005735.1 |
466 |
00000038 |
22 |
CHEK2 |
transcript variant 4 |
NM_001257387.1 |
NP_001244316.1 |
466 |
00000039 |
16 |
CYLD |
cylindromatosis (turban tumor syndrome), transcript variant 2 |
NM_001042355.1 |
NP_001035814.1 |
100 |
00000040 |
16 |
CYLD |
cylindromatosis (turban tumor syndrome), transcript variant 3 |
NM_001042412.1 |
NP_001035877.1 |
100 |
00000041 |
16 |
CYLD |
cylindromatosis (turban tumor syndrome), transcript variant 1 |
NM_015247.2 |
NP_056062.1 |
100 |
00000042 |
11 |
DDB2 |
damage-specific DNA binding protein 2, 48kDa |
NM_000107.2 |
NP_000098.1 |
162 |
00000043 |
14 |
DICER1 |
dicer 1, ribonuclease type III, transcript variant 3 |
NM_001195573.1 |
NP_001182502.1 |
201 |
00000044 |
14 |
DICER1 |
dicer 1, ribonuclease type III, transcript variant 4 |
NM_001271282.1 |
NP_001258211.1 |
201 |
00000045 |
14 |
DICER1 |
dicer 1, ribonuclease type III, transcript variant 2 |
NM_030621.3 |
NP_085124.2 |
201 |
00000046 |
14 |
DICER1 |
dicer 1, ribonuclease type III, transcript variant 1 |
NM_177438.2 |
NP_803187.1 |
201 |
00000047 |
2 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2, transcript variant 2 |
NM_001257281.1 |
NP_001244210.1 |
394 |
00000048 |
2 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2, transcript variant 3 |
NM_001257282.1 |
NP_001244211.1 |
114 |
00000049 |
2 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2, transcript variant 1 |
NM_152383.4 |
NP_689596.4 |
394 |
00000050 |
7 |
EGFR |
transcript variant 1 |
NM_005228.3 |
NP_005219.2 |
375 |
00000051 |
7 |
EGFR |
transcript variant 2 |
NM_201282.1 |
NP_958439.1 |
156 |
00000052 |
7 |
EGFR |
transcript variant 3 |
NM_201283.1 |
NP_958440.1 |
72 |
00000053 |
7 |
EGFR |
transcript variant 4 |
NM_201284.1 |
NP_958441.1 |
164 |
00000054 |
2 |
EPCAM |
epithelial cell adhesion molecule |
NM_002354.2 |
NP_002345.2 |
129 |
00000055 |
19 |
ERCC2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2, transcript variant 1 |
NM_000400.3 |
NP_000391.1 |
224 |
00000056 |
19 |
ERCC2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2, transcript variant 2 |
NM_001130867.1 |
NP_001124339.1 |
126 |
00000057 |
2 |
ERCC3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
NM_000122.1 |
NP_000113.1 |
215 |
00000058 |
16 |
ERCC4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
NM_005236.2 |
NP_005227.1 |
193 |
00000059 |
13 |
ERCC5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
NM_000123.3 |
NP_000114.2 |
422 |
00000060 |
8 |
EXT1 |
exostosin glycosyltransferase 1 |
NM_000127.2 |
NP_000118.2 |
57 |
00000061 |
11 |
EXT2 |
transcript variant 1 |
NM_000401.3 |
NP_000392.3 |
125 |
00000062 |
11 |
EXT2 |
transcript variant 2 |
NM_207122.1 |
NP_997005.1 |
125 |
00000063 |
11 |
EXT2 |
transcript variant 3 |
NM_001178083.1 |
NP_001171554.1 |
125 |
00000064 |
7 |
EZH2 |
enhancer of zeste homolog 2 (Drosophila), transcript variant 3 |
NM_001203247.1 |
NP_001190176.1 |
121 |
00000065 |
7 |
EZH2 |
enhancer of zeste homolog 2 (Drosophila), transcript variant 4 |
NM_001203248.1 |
NP_001190177.1 |
121 |
00000066 |
7 |
EZH2 |
enhancer of zeste homolog 2 (Drosophila), transcript variant 5 |
NM_001203249.1 |
NP_001190178.1 |
121 |
00000067 |
7 |
EZH2 |
enhancer of zeste homolog 2 (Drosophila), transcript variant 1 |
NM_004456.4 |
NP_004447.2 |
121 |
00000068 |
7 |
EZH2 |
enhancer of zeste homolog 2 (Drosophila), transcript variant 2 |
NM_152998.2 |
NP_694543.1 |
121 |
00000069 |
16 |
FANCA |
Fanconi anemia, complementation group A, transcript variant 1 |
NM_000135.2 |
NP_000126.2 |
669 |
00000070 |
16 |
FANCA |
Fanconi anemia, complementation group A, transcript variant 2 |
NM_001018112.1 |
NP_001018122.1 |
137 |
00000071 |
X |
FANCB |
Fanconi anemia, complementation group B, transcript variant 1 |
NM_001018113.1 |
NP_001018123.1 |
85 |
00000072 |
X |
FANCB |
Fanconi anemia, complementation group B, transcript variant 2 |
NM_152633.2 |
NP_689846.1 |
85 |
00000073 |
9 |
FANCC |
Fanconi anemia, complementation group C, transcript variant 1 |
NM_000136.2 |
NP_000127.2 |
163 |
00000074 |
9 |
FANCC |
Fanconi anemia, complementation group C, transcript variant 2 |
NM_001243743.1 |
NP_001230672.1 |
163 |
00000075 |
9 |
FANCC |
Fanconi anemia, complementation group C, transcript variant 3 |
NM_001243744.1 |
NP_001230673.1 |
157 |
00000076 |
3 |
FANCD2 |
Fanconi anemia, complementation group D2, transcript variant 2 |
NM_001018115.1 |
NP_001018125.1 |
1004 |
00000077 |
3 |
FANCD2 |
Fanconi anemia, complementation group D2, transcript variant 1 |
NM_033084.3 |
NP_149075.2 |
1004 |
00000078 |
6 |
FANCE |
Fanconi anemia, complementation group E |
NM_021922.2 |
NP_068741.1 |
234 |
00000079 |
11 |
FANCF |
Fanconi anemia, complementation group F |
NM_022725.3 |
NP_073562.1 |
102 |
00000080 |
9 |
FANCG |
Fanconi anemia, complementation group G |
NM_004629.1 |
NP_004620.1 |
79 |
00000081 |
15 |
FANCI |
Fanconi anemia, complementation group I, transcript variant 1 |
NM_001113378.1 |
NP_001106849.1 |
412 |
00000082 |
15 |
FANCI |
Fanconi anemia, complementation group I, transcript variant 2 |
NM_018193.2 |
NP_060663.2 |
412 |
00000083 |
2 |
FANCL |
Fanconi anemia, complementation group L, transcript variant 1 |
NM_001114636.1 |
NP_001108108.1 |
192 |
00000084 |
2 |
FANCL |
Fanconi anemia, complementation group L, transcript variant 2 |
NM_018062.3 |
NP_060532.2 |
192 |
00000085 |
14 |
FANCM |
Fanconi anemia, complementation group M |
NM_020937.2 |
NP_065988.1 |
309 |
00000086 |
1 |
FH |
fumarate hydratase |
NM_000143.3 |
NP_000134.2 |
80 |
00000087 |
17 |
FLCN |
transcript variant 1 |
NM_144997.5 |
NP_659434.2 |
191 |
00000088 |
17 |
FLCN |
transcript variant 2 |
NM_144606.5 |
NP_653207.1 |
167 |
00000089 |
3 |
GATA2 |
transcript variant 1 |
NM_001145661.1 |
NP_001139133.1 |
46 |
00000090 |
3 |
GATA2 |
transcript variant 2 |
NM_032638.4 |
NP_116027.2 |
46 |
00000091 |
3 |
GATA2 |
transcript variant 3 |
NM_001145662.1 |
NP_001139134.1 |
46 |
00000092 |
X |
GPC3 |
transcript variant 1 |
NM_001164617.1 |
NP_001158089.1 |
81 |
00000093 |
X |
GPC3 |
transcript variant 2 |
NM_004484.3 |
NP_004475.1 |
81 |
00000094 |
X |
GPC3 |
transcript variant 3 |
NM_001164618.1 |
NP_001158090.1 |
81 |
00000095 |
X |
GPC3 |
transcript variant 4 |
NM_001164619.1 |
NP_001158091.1 |
81 |
00000096 |
12 |
HNF1A |
HNF1 homeobox A |
NM_000545.5 |
NP_000536.5 |
181 |
00000097 |
11 |
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 3 |
NM_001130442.1 |
NP_001123914.1 |
52 |
00000098 |
11 |
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
NM_005343.2 |
NP_005334.1 |
52 |
00000099 |
11 |
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 2 |
NM_176795.3 |
NP_789765.1 |
52 |
00000100 |
4 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 1 |
NM_000222.2 |
NP_000213.1 |
267 |
00000101 |
4 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
NM_001093772.1 |
NP_001087241.1 |
267 |
00000102 |
14 |
MAX |
transcript variant 1 |
NM_002382.4 |
NP_002373.3 |
24 |
|
« First |
Prev |
|
1 |
2 |
3 |
|
Next |
Last » |